FDA
-
Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes
Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.
By Elise Reuter • Feb. 27, 2025 -
‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts
The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, investors said.
By Gwendolyn Wu • Feb. 27, 2025 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
CAP urges HHS to revoke lab developed test rule, citing Trump order
The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for federal agencies to “alleviate unnecessary regulatory burdens.”
By Nick Paul Taylor • Feb. 26, 2025 -
FDA brings back some fired device staff
An industry source said “most, if not all” of the people at the CDRH who were recently dismissed are now being asked to return.
By Elise Reuter • Feb. 24, 2025 -
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
By Susan Kelly • Feb. 24, 2025 -
In FDA job cuts, experts see threat of far-reaching impact
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf.
By Jonathan Gardner , Delilah Alvarado • Feb. 21, 2025 -
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.
By Elise Reuter • Feb. 20, 2025 -
Medtronic nears FDA submission for Hugo robot
CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by the end of March.
By Ricky Zipp • Feb. 18, 2025 -
RFK Jr. confirmed as HHS secretary
Robert F. Kennedy Jr., a prominent vaccine critic, was confirmed Thursday by the U.S. Senate in a 52-48 vote to serve as the nation’s top health official.
By Emily Olsen • Feb. 13, 2025 -
Retrieved from Screenshot: The Food and Drug Administration.
Judge orders FDA, health agencies to restore removed webpages
District Judge John Bates wrote the removals harm “everyday Americans, and most acutely, underprivileged Americans, seeking healthcare.”
By Elise Reuter • Feb. 12, 2025 -
Trump orders agencies to plan for ‘large-scale’ job cuts
While Trump’s executive order provides substantial power to Elon Musk’s DOGE effort, it’s not specifically targeted to health agencies like the FDA.
By Ned Pagliarulo • Feb. 12, 2025 -
FDA posts early alert about BD device linked to 30 injuries, 4 deaths
The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.
By Nick Paul Taylor • Feb. 10, 2025 -
Medtronic recall of brain fluid drainage systems linked to 15 injuries
The company will keep the systems on the market but is asking providers to check devices for visible cracks and return affected devices.
By Nick Paul Taylor • Feb. 4, 2025 -
RFK Jr. clears key hurdle on path to HHS secretary
A key Senate committee voted to advance Robert F. Kennedy’s nomination even after some legislators raised concerns about his previous vaccine stances and confusion surrounding programs like Medicare and Medicaid.
By Sydney Halleman , Delilah Alvarado , Jonathan Gardner • Feb. 4, 2025 -
Retrieved from Olympus on February 03, 2025
FDA labels recall of discontinued Olympus endoscope part as Class I
The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device.
By Susan Kelly • Feb. 3, 2025 -
Troy Tazbaz, CDRH digital health leader, resigns
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.
By Elise Reuter • Jan. 31, 2025 -
2025 outlook
Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty
Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.
By Ricky Zipp • Jan. 31, 2025 -
FDA warns about patient monitor cybersecurity vulnerabilities
Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the devices, the FDA warned.
By Nick Paul Taylor • Jan. 31, 2025 -
Retrieved from Screenshot: The Food and Drug Administration.
FDA webpages on clinical trial diversity removed after Trump orders
The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, a physician said.
By Elise Reuter • Jan. 27, 2025 -
Sara Brenner named acting FDA commissioner
Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new leader is confirmed.
By Elise Reuter • Jan. 24, 2025 -
Senate sets date to vet RFK Jr.’s nomination to lead HHS
The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.
By Kristin Jensen • Jan. 23, 2025 -
Retrieved from Mass General Brigham on January 22, 2025Deep Dive // 2025 outlook
AI in medtech is taking off. Here are 4 trends to watch in 2025.
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain around insurance coverage and generative AI.
By Elise Reuter • Jan. 22, 2025 -
Tarver warns that US device supply chain vulnerabilities could harm patients
The new director of the FDA’s device center contrasted a European rule with the lack of mandatory reporting requirements for potential device shortages in the U.S.
By Nick Paul Taylor • Jan. 17, 2025 -
Retrieved from Hologic on January 16, 2025
Hologic receives FDA warning letter over Biozorb implantable markers
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
By Elise Reuter • Updated Jan. 16, 2025 -
Philips recall of heart monitor software tied to 109 injuries, 2 deaths
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.
By Ricky Zipp • Jan. 14, 2025